Stephen Grant

Dr. Stephen Grant joined NDA Partners as an Expert Consultant in 2021. He is a board-certified Cardiologist who during his more than 20-year career at FDA served in senior leadership roles in the Center for Drug Evaluation and Research (CDER) as Deputy Director, Division of Cardiovascular and Renal Products (DCRP) and Acting Associate Director, Medical and Scientific Affairs in the Office of Compliance. He also served as a Clinical Reviewer in the Office of Therapeutics Research and Review and as Team Leader in the Office of Cellular, Tissue, and Gene Therapies in the Center for Biologics Evaluation and Research (CBER), in addition to serving as Clinical Reviewer and Team Leader in DCRP.

Dr. Grant is an expert in pre-market development of drugs and combination products with extensive experience in the design, analysis, and interpretation of clinical efficacy and safety studies of investigational and marketed drugs and devices, and in the FDA regulation of therapeutic and diagnostic products. In addition to his FDA career, he was the Chief Medical Officer of Celladon Corp. and a practicing physician in general cardiology.